Eris Lifesciences inches up on the BSE
Eris Lifesciences is currently trading at Rs. 1801.45, up by 0.60 points or 0.03% from its previous closing of Rs. 1800.85 on the BSE.
The scrip opened at Rs. 1794.05 and has touched a high and low of Rs. 1805.00 and Rs. 1792.20 respectively. So far 1471 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1909.55 on 12-Jun-2025 and a 52 week low of Rs. 1130.05 on 28-Jan-2025.
Last one week high and low of the scrip stood at Rs. 1816.95 and Rs. 1703.05 respectively. The current market cap of the company is Rs. 24470.23 crore.
The promoters holding in the company stood at 54.83%, while Institutions and Non-Institutions held 26.57% and 18.59% respectively.
Eris Lifesciences has received approval for manufacturing unit in its Ahmedabad campus from ANVISA, which is Brazil’s national health regulatory agency. This approval follows a successful inspection conducted by the agency in May 2025 and enables the company to enter Brazil, the largest pharmaceutical market in South America.
Eris Lifesciences develops, manufactures and commercializes branded pharmaceutical products in select therapeutic areas within the chronic and acute categories of the IPM, such as: cardiovascular; anti-diabetics; vitamins; gastroenterology; and anti-infectives.
